Clinical Research News Online
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • Press Releases
    • Post Press Releases
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Recorded Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • Clinical Trainings
    • Clinical Conferences
    • Clinical Trial Innovation Summit
    • Barnett International
  • About
    • Editorial Calendar
    • Editorial Profile
    • Contact Us
    • Submit a Story
  • SCOPE Summit
    • SCOPE Summit – US
    • SCOPE Summit – Europe
    • European Innovations Awards
 
 
 
 
  • Why Leveraging Technology Is The Key To Improving Healthcare

    Forbes |  Technology is vital if the healthcare industry wants to continue to improve the quality of its services.

    Jan 4, 2017
  • New FDA Drug Approvals Breaking Down the Numbers

    RAPS |  If a decline in US Food and Drug Administration (FDA) approvals of new pharmaceuticals is a bad sign for the industry, then 2016 was the worst year since 2010. But maybe that's not all bad.

    Jan 4, 2017
  • 21st Century Cures Act Clarifies (And Somewhat Reduces) Regulation of Stand Alone Software Products Used In Healthcare

    FDA Law Blog |  This post focuses on only one section of the new law: Section 3060, "Clarifying Medical Software Regulation."

    Jan 3, 2017
  • Gates Foundation Sends $140M to Intarcia for HIV Version of Pump

    Xconomy |  Intarcia Therapeutics, a Boston biotech that's developing a tiny, implantable drug-delivery pump for type 2 diabetes, is now broadening its focus to HIV backed by as much as $140 million from the Bill & Melinda Gates Foundation.

    Dec 29, 2016
  • Amyloid Hypothesis For Alzheimers In Doubt After Lillys Drug Failure

    NPR.org |  The failure of an experimental drug that targets clumps of protein inside the brains of Alzheimer's patients called into question one of the leading theories about the cause of the dementia.

    Dec 29, 2016
  • Liver Damage Patient Deaths Lead FDA to Halt SeaGen Leukemia Trials

    Xconomy |  Seattle Genetics' work to develop a drug to treat a form of leukemia has hit a roadblock following the deaths of four patients in clinical trials. The FDA placed a clinical hold or partial holds on three early-stage trials evaluating the company's drug.

    Dec 28, 2016
  • The Case For eConsent Integration

    Clinical Informatics News Contributed Commentary | The introduction of electronic informed consent (eConsent) solutions to communicate study information, while supporting the management of informed consent processes, offers huge improvements to participant on-boarding in today’s clinical trials.

    Dec 27, 2016
  • Almac Clinical Technologies, Commonwealth Informatics, Linguamatics, And Centrexion Therapeutics: News From December 2016

    Clinical Informatics News Briefs | News, products, and partnerships from around the clinical trial and healthcare community including news from Almac Clinical Technologies, Commonwealth Informatics, Linguamatics, and Centrexion Therapeutics.

    Dec 21, 2016
  • FDA Officials Call for Including Adolescents in Adult Oncology Trials

    RAPS |  A team of officials at the FDA are calling for a "culture shift" by drugmakers, regulators and clinical investigators to encourage enrolling more adolescent patients in relevant "adult-type" cancer clinical trials. The officials made the call in a recent article in Clinical Cancer Research, where they argue that excluding older adolescents, ages 12 to 17, from adult oncology trials leads to delayed access to new treatments for those patients.

    Dec 20, 2016
  • SCOPE Preview: Clinical Data Strategy, Real World Data, And Precision Medicine

    Clinical informatics News | Clinical Informatics News will be attending the Summit for Clinical Ops Executives—SCOPE—in Miami, Fla. from January 24-26, 2017. Here’s some of what we have flagged so far.

    Dec 19, 2016
  • Obama Signs 21st Century Cures Act Into Law

    STAT |  President Obama signed the 21st Century Cures Act into law today. Surrounded by Vice President Joe Biden and the bipartisan lawmakers who helped push the bill through, Obama commented, "It's a good day to see us doing our jobs."

    Dec 13, 2016
  • Complexities of Consent

    Clinical Informatics News | As genomics continues to grow and evolve, the need to find a balance between scientific progress and patient protection is as great as ever. 

    Dec 13, 2016
  • Fred Hutch's New Bezos Family Immunotherapy Clinic Could Change the Game for Cancer Treatment

    GeekWire |  Immunotherapy is simple in theory, but endlessly complex in practice. The new Bezos Family Immunotherapy Clinic at the Fred Hutchinson Cancer Research Center is designed specifically to fuel the research of immunotherapy treatments.

    Dec 12, 2016
  • The Cancer Lottery

    MIT Technology Review |  Finding telltale mutations in tumors and targeting those cancers with precisely selected drugs is the newest front in the war on cancer. Now researchers just have to figure out why it doesn't work for everyone.

    Dec 12, 2016
  • Baskets and Umbrellas: Trial Design for Precision Oncology

    Clinical Informatics News Brief | An article published online on JAMA Oncology’s Patient Page yesterday proposes two types of clinical trial for testing precision medicine treatments of oncology.

    Dec 9, 2016
  • FDA Says Real-World Evidence Could Generate Incorrect or Unreliable Conclusions

    RAPS |  Fifteen top FDA officials published an article in the New England Journal of Medicine this morning attempting to clarify a definition for real-world evidence (RWE), and flagging areas of promise and concern.

    Dec 8, 2016
  • ERT Acquires Exco InTouch

    Clinical Informatics News Brief | ERT announced this morning that it has acquired Exco InTouch. Financial terms of the transaction were not disclosed.

    Dec 8, 2016
  • «
  • 211
  • 212
  • 213
  • 214 (current)
  • 215
  • 216
  • 217
  • 218
  • 219
  • 220
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy